Author details

Full Name

Maximilian Kauer

Affiliation

St. Anna Children's Cancer Research Institute (CCRI)

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36054432	Human repair-related Schwann cells adopt functions of antigen-presenting cells in vitro.	Glia	2022
36054432	Human repair-related Schwann cells adopt functions of antigen-presenting cells in vitro.	Glia	2022
33419969	YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.	Oncogenesis	2021
33712610	Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8.	Nat Commun	2021
33419969	YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.	Oncogenesis	2021
33712610	Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8.	Nat Commun	2021
30296338	JAG2 signaling induces differentiation of CD14<sup>+</sup> monocytes into Langerhans cell histiocytosis-like cells.	J Leukoc Biol	2019
30296338	JAG2 signaling induces differentiation of CD14<sup>+</sup> monocytes into Langerhans cell histiocytosis-like cells.	J Leukoc Biol	2019
30705095	CD371 cell surface expression: a unique feature of <i>DUX4</i>-rearranged acute lymphoblastic leukemia.	Haematologica	2019
31406155	Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.	Cell Death Dis	2019
31406155	Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.	Cell Death Dis	2019
30705095	CD371 cell surface expression: a unique feature of <i>DUX4</i>-rearranged acute lymphoblastic leukemia.	Haematologica	2019
30038364	Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.	Cell Death Dis	2018
30123424	Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.	Oncotarget	2018
30038364	Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.	Cell Death Dis	2018
30123424	Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.	Oncotarget	2018
28030800	The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.	Oncotarget	2017
28671673	EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.	Oncogene	2017
28482719	MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy.	Leuk Lymphoma	2017
28924177	Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response.	Sci Rep	2017
27760381	High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.	Gene	2017
28030800	The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.	Oncotarget	2017
28160567	EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.	Oncotarget	2017
28482719	MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy.	Leuk Lymphoma	2017
28160567	EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.	Oncotarget	2017
28671673	EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.	Oncogene	2017
28924177	Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response.	Sci Rep	2017
27760381	High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.	Gene	2017
27282934	EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.	FEBS Lett	2016
27282934	EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.	FEBS Lett	2016
26657295	Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.	Oncotarget	2016
26327566	Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia.	Leuk Lymphoma	2016
27735950	Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.	Cell Death Dis	2016
26657295	Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.	Oncotarget	2016
26327566	Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia.	Leuk Lymphoma	2016
27735950	Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.	Cell Death Dis	2016
25515960	The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.	Blood	2015
25712098	EWS-FLI1 employs an E2F switch to drive target gene expression.	Nucleic Acids Res	2015
25410853	Identification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection.	J Virol	2015
25515960	The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.	Blood	2015
26360775	Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.	PLoS One	2015
26360775	Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.	PLoS One	2015
25712098	EWS-FLI1 employs an E2F switch to drive target gene expression.	Nucleic Acids Res	2015
25410853	Identification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection.	J Virol	2015
23995784	Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.	Oncogene	2014
25281719	Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.	Cancer Res	2014
23995784	Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.	Oncogene	2014
24240203	Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia.	Leukemia	2014
25281719	Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.	Cancer Res	2014
24240203	Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia.	Leukemia	2014

1 - 50 of 92

Marta Gut

Universitat de Barcelona (UB)

Career Start Year 2010

Number of shared co-authors 2

Riyue Bao

UPMC Hillman Cancer Center

Career Start Year 2007

Number of shared co-authors 0

Amit U Sinha

Memorial Sloan Kettering Cancer Center

Career Start Year 2007

Number of shared co-authors 0

Yue Lu

The University of Texas MD Anderson Cancer Center

Career Start Year 2006

Number of shared co-authors 0

Xiaotu Ma

St. Jude Children's Research Hospital

Career Start Year 2006

Number of shared co-authors 5

Maciej Paszkowski-Rogacz

Faculty of Medicine and University Hospital Carl Gustav Carus

Career Start Year 2005

Number of shared co-authors 0

Henry Yang

Cancer Science Institute of Singapore, National University of Singapore

Career Start Year 2005

Number of shared co-authors 0

Catrina Fronick

McDonnell Genome Institute, Washington University in St. Louis School of Medicine

Career Start Year 2004

Number of shared co-authors 0

Matthias Schlesner

University of Augsburg

Career Start Year 2004

Number of shared co-authors 4

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 0

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Laura Riva

Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 2003

Number of shared co-authors 0

Olivier Elemento

Meyer Cancer Center

Career Start Year 2002

Number of shared co-authors 0

Jacqueline E Payton

Washington University School of Medicine.

Career Start Year 2001

Number of shared co-authors 0

Sophia Derdak

Medical University of Vienna

Career Start Year 2001

Number of shared co-authors 1

Celine Lefebvre

The Scripps Research Institute

Career Start Year 1999

Number of shared co-authors 0

Ru-Fang Yeh

Genentech Inc.

Career Start Year 1999

Number of shared co-authors 0

Andrew J Gentles

Stanford Center for Biomedical Informatics Research, Stanford University

Career Start Year 1999

Number of shared co-authors 0

Martin Hirst

University of British Columbia

Career Start Year 1998

Number of shared co-authors 0

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 0

Benedikt Brors

German Cancer Research Center (DKFZ)

Career Start Year 1997

Number of shared co-authors 6

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 0

Robert S Fulton

McDonnell Genome Institute, Washington University School of Medicine

Career Start Year 1994

Number of shared co-authors 1

Samuel Aparicio

University of British Columbia

Career Start Year 1993

Number of shared co-authors 1

Marco A Marra

University of British Columbia

Career Start Year 1993

Number of shared co-authors 1

Wenbin Wei

Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield

Career Start Year 1991

Number of shared co-authors 1

Glenn S Cowley

Broad Institute of Harvard and MIT

Career Start Year 1990

Number of shared co-authors 0

Todd R Golub

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 1

David A Wheeler

Baylor College of Medicine

Career Start Year 1984

Number of shared co-authors 1

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 0

row(s) 1 - 30 of 30

Heinrich Kovar

St. Anna Children's Cancer Research Institute (CCRI), Medical University Vienna

Co-authored papers 23

Raphaela Schwentner

Children's Cancer Research Institute

Co-authored papers 16

Jozef Ban

Children's Cancer Research Institute

Co-authored papers 10

Reinhard Kofler

Medical University of Innsbruck

Co-authored papers 7

Gunhild Jug

Children's Cancer Research Institute

Co-authored papers 6

Eleni M Tomazou

St. Anna Children's Cancer Research Institute (CCRI)

Co-authored papers 5

Aykut Uren

Georgetown University Medical Center

Co-authored papers 4

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 4

Peter F Ambros

Children's Cancer Research Institute, Medical University of Vienna

Co-authored papers 4

Sabine Taschner-Mandl

St. Anna Children's Cancer Research Institute

Co-authored papers 4

G??nther H S Richter

Children's Cancer Research Center

Co-authored papers 3

Richard Moriggl

Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna

Co-authored papers 3

Inge M Ambros

St. Anna Children's Cancer Research Institute

Co-authored papers 3

Michael Dworzak

St. Anna Children's Cancer Research Institute (CCRI)

Co-authored papers 3

Marc Wiedner

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences

Co-authored papers 3

Sven Bilke

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 2

Fan Yang

West China Second Hospital, Sichuan University

Co-authored papers 2

Caroline Hutter

Children's Cancer Research Institute, Medical University of Vienna

Co-authored papers 2

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 2

Susan R Davis

Co-authored papers 2

Kristiina Iljin

VTT Technical Research Centre of Finland Ltd

Co-authored papers 2

Elizabeth R Lawlor

Seattle Children's Research Institute

Co-authored papers 2

Reinhard Windhager

Medical University of Vienna

Co-authored papers 2